Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III

Sagnik Chatterjee(Bristol-Myers Squibb (United States)), Hong Shen, Yueping Zhang(Institute of Vegetables and Flowers), L.V.J. Sankara Sivaprasad(Bristol-Myers Squibb (United States)), Vijaykumar Kuchibhotla(Bristol-Myers Squibb (United States)), Manjunath Ramarao(Bristol-Myers Squibb (United States)), Avisek Deyati(Bristol-Myers Squibb (United States)), Sushma Basavanthappa(Bristol-Myers Squibb (United States)), Avinash A. Hadambar(Bristol-Myers Squibb (United States)), Shashyendra Singh Gautam(Bristol-Myers Squibb (United States)), Michael Sinz(Rutgers, The State University of New Jersey), Sambuddho Mukherjee(Bristol-Myers Squibb (United States)), Bokka Venkata Murali(Bristol-Myers Squibb (United States)), T. Thanga Mariappan(Bristol-Myers Squibb (Germany)), Bradley A. Zinker(Abbott (United States)), Tanvi Naik(Bristol-Myers Squibb (United States)), Gowtham Raj Gunti(Bristol-Myers Squibb (United States))
Journal of Pharmacology and Experimental Therapeutics
October 30, 2020
Cited by 19


Related Papers